Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Evolent Health, Inc Class A Common Stock (NY:EVH)

9.910 +0.070 (+0.71%)
Streaming Delayed Price Updated: 12:25 PM EDT, Apr 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Evolent Health, Inc Class A Common Stock

< Previous 1 2 3 4 5 Next >
Why Daktronics Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Daktronics, Inc. (NASDAQ: DAKT) moved lower during Tuesday’s session following weak quarterly results. 
Via Benzinga
Are You A Trader Or Investor: Biotech Momentum Is Picking Up
ETFs have not helped as portfolio fillers but they can identify trends. We should play this rally out of a biotech bear market. 
Via Talk Markets
Topics ETFs
Expedia Group, Gartner, Cloudflare, Cardinal Health And Other Big Stocks Moving Higher On Friday
U.S. stocks traded higher, with the Dow Jones gaining around 200 points on Friday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Topics Stocks
Exposures US Equities
30 US States Pause Medicaid Disenrollment Due To Technical Glitch
The U.S. 
Via Benzinga
Evolent Health (EVH) Q3 2023 Earnings Call Transcript
EVH earnings call for the period ending September 30, 2023. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Benzinga's Top Ratings Upgrades, Downgrades For October 16, 2023
Via Benzinga
Evolent Health (EVH) Q2 2023 Earnings Call Transcript
EVH earnings call for the period ending June 30, 2023. 
Via The Motley Fool
Earnings Outlook For Evolent Health
Via Benzinga
Analyst Ratings for Evolent Health
Via Benzinga
Evolent Health (EVH) Q1 2023 Earnings Call Transcript
EVH earnings call for the period ending March 31, 2023. 
Via The Motley Fool
Market Mixes It Up With A Broad Rally
Biotech stocks remain sluggish but the longer-term outlook for breakthrough therapies - gene therapy, obesity, CNS, RNA - remain positive. 
Via Talk Markets
Recap: Evolent Health Q1 Earnings
Via Benzinga
Small & Mid Cap Life Science Stock Portfolio: Some Good Picks In A Stalled Sector
A pivotal week looks to be shaping up with the usual macro concerns arising, such as a Fed meeting and big earnings waiting just around the corner. One possible path to help navigate around these macro... 
Via Talk Markets
Biotech And Life Science Trades: Q1 2023 Performance By The Numbers
Despite a strong month and a great finish to the quarter, many traders remain cautious about the market. It’s been a volatile time after the collapse of Silicon Valley Bank, but the first quarter of... 
Via Talk Markets
Evolent Health Q4 Top-Line Beats Expectation, Analyst Points To Visible Growth Outlook
Via Benzinga
Evolent Health (EVH) Q4 2022 Earnings Call Transcript
EVH earnings call for the period ending December 31, 2022. 
Via The Motley Fool
Cowen & Co. Maintains Outperform Rating for Evolent Health: Here's What You Need To Know
Via Benzinga
Why Evolent Health Stock Is Soaring Today
Investors are applauding Evolent's latest acquisition. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For April 12, 2023
Via Benzinga
SMID Cap Life Science Update: Are You An Investor Or Trader?
Despite choppy trading, there is an upward tilt to life science stocks since the 9/26/22 lows. 
Via Talk Markets
5 Analysts Have This to Say About Evolent Health
Via Benzinga
Evolent Health (EVH) Q3 2022 Earnings Call Transcript
EVH earnings call for the period ending September 30, 2022. 
Via The Motley Fool
When Small Cap Biotechs Lose Momentum: Are You An Investor Or A Trader?
A few small cap biotechs lost momentum last week so now might be the time to take profits. But many of these stocks are favored because of their core technology and favored by funds; time to buy? 
Via Talk Markets
Why InMed Pharmaceuticals Shares Tumbled 28%; Here Are 67 Biggest Movers From Friday
Gainers AGBA Group Holding Limited (NASDAQ: AGBA) gained 50.7% to close at $6.78 on Friday. 
Via Benzinga
Foot Locker, Ross Stores, Palo Alto Networks, And Other Big Gainers From Friday
U.S. stocks closed higher on Friday, with the Dow Jones gaining around 200 points. Here is the list of some big stocks recording gains in the previous session. 
Via Benzinga
This Analyst Is Bullish On Evolent Health's Recent Deal, Calls 'Highly Strategic Acquisition'
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Centene Agrees To Divest Magellan Specialty Health To Evolent Health
Via Benzinga
Why PaxMedica Shares Are Trading Higher By Over 53%? Here Are 47 Stocks Moving In Friday's Mid-Day Session
Gainers PaxMedica, Inc. (NASDAQ: PXMD) gained 53.5% to $2.38 after the company announced an equity investment agreement for up to $20 million with Lincoln Park Capital. 
Via Benzinga
Why Evolent Health Stock Sank by Over 6% Today
For the second time in nearly as many days, the company's shares got a price target haircut. 
Via The Motley Fool
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.